These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2904684)

  • 21. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S; Matsumoto K; Kitagawa T; Yamamoto J
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lyell's syndrome caused by Salazopyrine].
    Várkonyi V; Török I; Márta D; Makovitzky J
    Orv Hetil; 1976 Apr; 117(16):971-3. PubMed ID: 5694
    [No Abstract]   [Full Text] [Related]  

  • 25. Glandular fever-like illness associated with sulphasalazine.
    Carr-Locke DL; Ali M
    Postgrad Med J; 1982 Oct; 58(684):665-6. PubMed ID: 6129620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy of ulcerative colitis].
    Rückert Y
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
    Halmos B; Anastopoulos HT; Schnipper LE; Ballesteros E
    Ann Hematol; 2004 Apr; 83(4):242-6. PubMed ID: 13680174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A severe case of infectious mononucleosis associated with ciprofloxacin and salazopyrin administration].
    Miftode E; Leca D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):652-5. PubMed ID: 20201247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
    Yamakado S; Yoshida Y; Yamada T; Kishida T; Kobayashi M; Nomura T
    Intern Med; 1992 Jan; 31(1):108-13. PubMed ID: 1348965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6.
    Kunisaki Y; Goto H; Kitagawa K; Nagano M
    Intern Med; 2003 Feb; 42(2):203-7. PubMed ID: 12636244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic hypersensitivity reaction to mesacol.
    Sule A; Gaitonde S; Bhojani K; Mittal G; Balakrishnan C; Gurmeet M; Deshpande RB; Joshi VR
    J Assoc Physicians India; 2001 Nov; 49():1120-2. PubMed ID: 11868872
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis and mononucleosis syndrome related to the ingestion of salazosulfapyridine].
    Labadie H; Beaugrand M; Ferrier JP
    Rev Med Interne; 1986 Jan; 7(1):35-40. PubMed ID: 2871605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new case of hypersensitivity pneumopathy caused by salazopyrine?].
    Laurent K; De Jonghe M; Flemale A; Kimbimbi P; Defrance P; Gillard C
    Rev Pneumol Clin; 1985; 41(5):340-3. PubMed ID: 2869567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug-induced eosinophilia in 2 cases of ulcerative colitis].
    Matov V; Ianchev V; Dinkov L; Boneva M; Etŭrska M
    Vutr Boles; 1981; 20(1):103-7. PubMed ID: 6113706
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfasalazine-induced colitis complicating idiopathic ulcerative colitis.
    Ring FA; Hershfield NB; Machin GA; Scott RB
    Can Med Assoc J; 1984 Jul; 131(1):43-5. PubMed ID: 6145516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects and therapy of ulcerative colitis].
    Ziegler K
    Dtsch Z Verdau Stoffwechselkr; 1969; 29(4):319-29. PubMed ID: 4395145
    [No Abstract]   [Full Text] [Related]  

  • 38. Raynaud's phenomenon induced by sulphasalazine in a case of chronic ulcerative colitis.
    Ahmad J; Siddiqui MA; Khan AS; Afzall S
    J Assoc Physicians India; 1984 Apr; 32(4):370. PubMed ID: 6146597
    [No Abstract]   [Full Text] [Related]  

  • 39. Selected individual therapeutic problems in inflammatory bowel disease.
    Kirsner JB; Deutsch S; Hanauer SB
    Am J Gastroenterol; 1984 May; 79(5):368-75. PubMed ID: 6144267
    [No Abstract]   [Full Text] [Related]  

  • 40. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.